Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL) · High-grade B-cell Lymphoma (HGBL) · Transformed Follicular Lymphoma (TFL) · Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Seoul National University Hospital, Seoul, Seoul, South Korea
Contact: Principal Investigator (Youngil Koh)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Relapsed Large B-cell Lymphoma · Refractory Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea · Seoul, South Korea

Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Lymphoma · Waldenström Macroglobulinemia (WM) · DLBCL - Diffuse Large B Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Richmond, Australia · Nedlands, Australia

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

B-Cell Non-Hodgkin's Lymphoma (NHL) · Lymphoma, Non-Hodgkins · Lymphomas Non-Hodgkin's B-Cell

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sacramento, United States · Dallas, United States